eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
2/2001
vol. 5
 
Share:
Share:
more
 
 
abstract:

Combined treatment of extranodular lymphoma localised in head and neck

Janusz Skowronek
,
Zbigniew Nyczak

Współcz Onkol (2001) vol. 5, 2 (74-77)
Online publish date: 2003/07/11
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose: Lymphoma localized in
head and neck region often has an individual course of disease different from lymphoma localized in other organs. In most of cases it’s only one of symptoms of disseminated disease. Patients are treated with different methods. Most often combined treatment comprising of chemotherapy, radiotherapy and sometimes surgery is recommended. In some cases surgical treatment is a treatment of choice. We present results of treatment of patients with extranodular lymphoma localized in head and neck region.

Material and methods: 19 patients with head and neck lymphoma (11 women, 8 men) were treated between 1991 and 1999 in Greatpoland Cancer Center. Age of patients was from 17 to 74 years, average – 53,5. In 12 cases primary lesion was palatine tonsil, in 5 – nasopharynx and oropharynx, in 2 – maxillary sinus and nasal cavity. Lymphoma of low malignancy was diagnosed in 10 cases, in 4 cases – of high malignancy, in 2 cases – MALT lymphoma, in 2 cases – lymphoepithelioma, in 1 case – lymphoma of undifferentiated type.

5 patients were treated by surgery, radiotherapy and chemotherapy, 4 by surgery and radiotherapy, and 10 by radiotherapy and chemotherapy. In chemotherapy most often schema CHOP (14 patients) was used. Total doses of radiotherapy were from 20 to 60 Gy.

Results: In 15 cases total remission was observed in first and third month after the end of treatment. In 2 cases – partial remission. In 2 cases progression was observed. 5 years survived 7 patients (36,8 proc.), 3 years survived 11 patients (57,9 proc.). Women tend to demonstrate longer free of disease survival then man – 44,2 versus 36 month.

Conclusions: 1) patients with head and neck lymphoma need another treatment schema than patients with disseminated illness; 2) women tend to achieve longer free of disease survival time.
keywords:

head and neck lymphoma, radiotherapy, chemotherapy

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.